authors
- Major, Pierre
- Trarbach, T
- Lenz, H
- Kerr, D
- Pendergrass, K
- Douillard, J
- Chen, B
- Laurent, D
- Jacques, C
- Van Cutsem, E
A meta-analysis of two randomized, double-blind, placebo-controlled, phase III studies in patients (pts) with metastatic colorectal cancer (mCRC) receiving FOLFOX4 and PTK/ZK to determine clinical benefit on progression-free survival (PFS) in high LDH pts.
Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- June 20, 2006
has subject area
- 1103 Clinical Sciences (FoR)
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Journal of Clinical Oncology Journal